In contrast, alterations in the known breast cancer biomarkers HER2 (ERBB2) (Fig. 5b), ER (ESR1) (Fig. 5c), and PIK3CA (Fig. 5d) showed no correlation with overall survival in the same invasive breast cancer data set we examined for BRF2 alterations. This evidence concerns the gene BRF2 and breast cancer.